Clinical Trial Update: Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for early treatment in vulnerable individuals with non-severe SARS-CoV-2 infection spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome Coronavirus 2

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Covid19, Covid19 Drug Treatment | Phase 2, Phase 3 | Status: UNKNOWN